申请人:Pringle Wallace C.
公开号:US20100297035A1
公开(公告)日:2010-11-25
Thiazole amides, imidazole amides and related analogues of the Formula: are provided, in which variables are as described herein. Such compounds may be used to modulate ligand binding to histamine H3 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of central nervous system (CNS) and other disorders in humans, domesticated companion animals and livestock animals. Compounds provided herein may be administered alone or in combination with one or more other CNS agents to potentiate the effects of the other CNS agent(s). Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such ligands for detecting histamine H3 receptors (e.g., receptor localization studies).
本发明提供了式子中所述的噻唑酰胺、咪唑酰胺及其相关类似物,其中变量如本文所述。这些化合物可用于调节组织胺H3受体在体内或体外的配体结合,并且在治疗人类、家畜宠物和牲畜等各种中枢神经系统(CNS)和其他疾病中特别有用。本文提供的化合物可单独或与一个或多个其他CNS药剂联合使用以增强其他CNS药剂的效果。本文还提供了用于治疗此类疾病的制药组合物和方法,以及用于检测组织胺H3受体的配体(例如受体定位研究)的方法。